Most oncological pancreas resections must consider the mesopancreas.

Authors: Safi, S. A., David, S., Haeberle, L., Vaghiri, S., Luedde, T., Roderburg, C., Esposito, I., Fluegen, G., Knoefel, W. T.

Source: BMC Cancer; 2/4/2025, Vol. 25 Issue 1, p1-9, 9p

Subject Terms: NEOADJUVANT chemotherapy, SURGICAL margin, PANCREATIC duct, PANCREATIC cancer, PANCREATICODUODENECTOMY

Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival

Authors: Safi, S.-A., Haeberle, L., Fluegen, G., Lehwald-Tywuschik, N., Krieg, A., Keitel, V., Luedde, T., Esposito, I., Rehders, A., Knoefel, W.T.

Source: In Pancreatology June 2021 21(4):787-795

Defining distal splenopancreatectomy by the mesopancreas.

Authors: Safi, S.-A., Alexander, A., Neuhuber, W., Haeberle, L., Rehders, A., Luedde, T., Esposito, I., Fluegen, G., Knoefel, W. T.

Source: Langenbeck's Archives of Surgery; 4/16/2024, Vol. 409 Issue 1, p1-11, 11p

Subject Terms: SURGICAL margin, PANCREATIC duct, NEOADJUVANT chemotherapy, OVERALL survival, PANCREATECTOMY, PROGNOSIS

Geographic Terms: LEEDS (England)

Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments

Authors: Fluegen, G., Avivar-Valderas, A., Wang, Y., Padgen, M. R., Williams, J. K., Nobre, A. R., Calvo, V., Cheung, J. F., Bravo-Cordero, J. J., Entenberg, D.

Source: NATURE CELL BIOLOGY. 19(2):120-132

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN383287076&indx=1&recIds=ETOCRN383287076

The Relationship Between Dormant Cancer Cells and Their Microenvironment

Authors: Linde, N., Fluegen, G., Aguirre-Ghiso, J. A.

Source: Advances in cancer research. 132:45-72

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN612069643&indx=1&recIds=ETOCRN612069643

Prognostischer Wert präoperativer Anämie und perioperativer Fremdbluttransfusion in der chirurgischen Therapie des Rektumkarzinoms

Authors: Kröpil, F., Nestler, T., Toeruen, M., Fluegen, G., Kraus, S., Krieg, A., Rehders, A., Vallböhmer, D., Knoefel, W.

Source: Zentralblatt für Chirurgie. 140(6):640-644

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100172956175.0x000001&indx=1&recIds=ETOCvdc_100172956175.0x000001

Surgical margin clearance and extended chemotherapy defines survival for synchronous oligometastatic liver lesions of the ductal adenocarcinoma of the pancreas.

Authors: Safi, S. A.¹ (AUTHOR), Fluegen, G.¹ (AUTHOR), Rehders, A.¹ (AUTHOR), Haeberle, L.² (AUTHOR), Fung, S.¹ (AUTHOR), Keitel, V.³ (AUTHOR), Krieg, A.¹ (AUTHOR), Knoefel, W. T.¹ (AUTHOR) knoefel@hhu.de, Lehwald-Tywuschik, N.¹ (AUTHOR)

Source: International Journal of Clinical Oncology. Oct2021, Vol. 26 Issue 10, p1911-1921. 11p.

Subject Terms: *SURGICAL margin, *SURVIVAL rate, *OVERALL survival, *PROGNOSIS, *PANCREAS, *SURGICAL excision

Site of relapse of ductal adenocarcinoma of the pancreas affects survival after multimodal therapy.

Authors: Safi, S. A., Lehwald-Tywuschik, N., Rehders, A., Fluegen, G., Haeberle, L., Keitel, V., Knoefel, W. T.

Source: BMC Surgery; 6/3/2021, Vol. 21 Issue 1, p1-9, 9p

Subject Terms: LIVER metastasis, PROGRESSION-free survival, PANCREAS, DISEASE relapse, ADENOCARCINOMA, COMBINED modality therapy, SURGICAL excision

Chapter Two - The Relationship Between Dormant Cancer Cells and Their Microenvironment

Authors: Linde, N., Fluegen, G., Aguirre-Ghiso, J.A.

Source: In Advances in Cancer Research 2016 132:45-71

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.